VTGN vs EVAX

Comparison between VistaGen Therapeutics Inc (VTGN, Company) and Evaxion Biotech A/S (EVAX, Company).

Both VTGN and EVAX are from the Healthcare sector.

5-Year PerformanceEVAX has outperformed VTGN, delivering a return of -60.9% compared to -62.2%

VTGN vs EVAX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	VTGN(COMPANY)	EVAX(COMPANY)
Market Cap	$26M	$25M
Max Drawdown	99.76%	99.79%
Sharpe Ratio	-0.15	0.85
5Y Beta	0.96	0.77
Industry	Biotechnology	Biotechnology
P/E Ratio	-0.35	-0.42
Forward P/E	N/A	3.57
PEG Ratio	-0.01	N/A
5Y EPS CAGR	-12.57%	N/A
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	N/A	-26.17%

Market Cap

Winner

VTGN

$26M

EVAX

$25M

Max Drawdown

Winner

VTGN

99.76%

EVAX

99.79%

Sharpe Ratio

VTGN

-0.15

Winner

EVAX

0.85

5Y Beta

VTGN

0.96

Winner

EVAX

0.77

Industry

VTGN

Biotechnology

EVAX

Biotechnology

P/E Ratio

VTGN

-0.35

Winner

EVAX

-0.42

Forward P/E

VTGN

N/A

EVAX

3.57

PEG Ratio

VTGN

-0.01

EVAX

N/A

5Y EPS CAGR

VTGN

-12.57%

EVAX

N/A

Debt to Equity

VTGN

0.00%

EVAX

0.00%

Free Cash Flow Yield

VTGN

N/A

EVAX

-26.17%

VTGN vs EVAX - Historical Returns

Returns include dividend reinvestment.

Period	VTGN	EVAX
1 month	+12.54%	-25.43%
3 months	+9.87%	-19.31%
6 months	-9.43%	-46.96%
1 year	-67.47%	+40.55%
5 years(CAGR)	-62.19%	-60.95%
10 years(CAGR)	-39.65%	N/A
Max(CAGR)	-43.34%	-61.28%

Winner

VTGN

+12.54%

EVAX

-25.43%

Winner

VTGN

+9.87%

EVAX

-19.31%

Winner

VTGN

-9.43%

EVAX

-46.96%

VTGN

-67.47%

Winner

EVAX

+40.55%

5Y(CAGR)

VTGN

-62.19%

Winner

EVAX

-60.95%

10Y(CAGR)

VTGN

-39.65%

EVAX

N/A

Max(CAGR)

Winner

VTGN

-43.34%

EVAX

-61.28%

VTGN vs EVAX - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

Year	VTGN	EVAX
2026	-1.30%	-35.24%
2025	-80.03%	+3.22%
2024	-42.72%	-88.42%
2023	+31.79%	-60.59%
2022	-95.07%	-61.24%
2021	-14.85%	-55.31%
2020	+158.67%	N/A
2019	-56.60%	N/A
2018	+29.31%	N/A
2017	-70.26%	N/A
2016	-46.71%	N/A